IO Biotech Inc (NASDAQ: IOBT) kicked off on Monday, down -9.11% from the previous trading day, before settling in for the closing price of $1.0. Over the past 52 weeks, IOBT has traded in a range of $0.32-$2.79.
A company in the Healthcare sector has dropped its sales by -27.25% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 14.48%. With a float of $49.27 million, this company’s outstanding shares have now reached $65.88 million.
IO Biotech Inc (IOBT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of IO Biotech Inc is 25.21%, while institutional ownership is 41.38%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.34 earnings per share (EPS), higher than consensus estimate (set at -0.35) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.32% during the next five years compared to -27.25% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
Take a look at IO Biotech Inc’s (IOBT) current performance indicators. Last quarter, stock had a quick ratio of 1.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
Let’s dig in a bit further. During the last 5-days, its volume was 4.65 million. That was better than the volume of 2.05 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 59.90%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 23.74%, which indicates a significant decrease from 57.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1378 in the past 14 days, which was lower than the 0.1729 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2880, while its 200-day Moving Average is $1.2327. However, in the short run, IO Biotech Inc’s stock first resistance to watch stands at $0.9759. Second resistance stands at $1.0428. The third major resistance level sits at $1.0908. If the price goes on to break the first support level at $0.8610, it is likely to go to the next support level at $0.8130. The third support level lies at $0.7461 if the price breaches the second support level.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
The company with the Market Capitalisation of 59.88 million has total of 65,880K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -95,490 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -26,220 K.
